RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a stronger RSV vaccine dose protect the vulnerable?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether one or two doses of the RSV vaccine Arexvy works better in people with weakened immune systems, such as those who have had a cell transplant. Participants will receive up to three vaccine doses over a year and be monitored for side effects and immune resp…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 30, 2026 15:49 UTC
-
Major trial launches for RSV vaccine in seniors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new RSV vaccine in 25,000 adults aged 60 and older. The goal is to see if a single shot can prevent lower respiratory tract infections caused by RSV. Researchers will also check the vaccine's safety and how well it triggers the immune system.
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 15:04 UTC
-
New study aims to protect vulnerable infants from dangerous RSV
Prevention Recruiting nowThis study is testing the safety of a monthly injection called palivizumab in infants and children under 2 years old who are at high risk for severe RSV disease. Participants will receive up to 5 injections over the study period. The goal is to see how safe the drug is and to tra…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: NA • Sponsor: AstraZeneca • Aim: Prevention
Last updated Apr 30, 2026 15:49 UTC
-
Massive health survey aims to uncover hidden disease hotspots in cambodia
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for antibodies against 57 different infectious diseases, including dengue, flu, and malaria. The goal is to map where and how these diseases spread, so health officials can design better prevention and control programs. Participants …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC